Jobs

Currently 3838 jobs


Candidates Login

Forgotten details?

CV Database

Let the jobs come to you!


Company Login

Site Newsletter

FREE!

Sign up for the pharmiweb.com newsletter

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

submit a press release
118 Press Releases
1 2 3 4 next page
DateTitleCompany
17 May 13 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis Sanofi,
Published by
Pharmiweb.com
24 Apr 13 Sanofi Pasteur to Provide 1.7 Billion Doses of Oral Polio Vaccine from 2013 to 2017 for Polio Eradication Sanofi Pasteur
22 Apr 13 Hexyon/Hexacima 6-in -1 Pediatric Vaccine Approved in Europe Sanofi
18 Apr 13 Sanofi reinforces its presence in Morocco Sanofi
12 Apr 13 Sanofi and PATH announce the Launch of Large-scale Production of Semisynthetic Artemisinin against Malaria Sanofi
12 Apr 13 Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval Sanofi Pasteur
08 Mar 13 Sanofi Launches 2013 Patient Group Bursary Scheme and Demonstrates Ongoing Commitment to Patient Empowerment Sanofi,
Published by
Just:: Health
06 Mar 13 Composition of the Board of Directors of Sanofi Sanofi
06 Mar 13 ZALTRAP®? (aflibercept) is now available in the UK for the treatment of advanced metastatic colorectal cancer (mCRC) Sanofi and Regeneron Pharmaceuticals, Inc,
Published by
Just:: Health PR
07 Feb 13 Sanofi FY 2012 - Interview with CEO Chris Viehbacher Sanofi,
Published by
Business Wire
30 Jan 13 London Drive Kicks off to Ensure Girls Are Protected against Cervical Cancer as the Capital Sees Lowest Vaccine Uptake Rates in England Sanofi Pasteur MSD,
Published by
PR Newswire
23 Nov 12 Sanofi Receives Positive CHMP Opinion in the European Union for Once-Daily Lyxumia® (lixisenatide) Sanofi,
Published by
Reynolds-MacKenzie
25 Oct 12 Sanofi Q3 2012 - Interview with CFO JĂ©rĂ´me Contamine Sanofi,
Published by
Business Wire
19 Oct 12 FDA Advisory Committee Recommends KYNAMRO™ for Homozygous Familial Hypercholesterolemia Genzyme a Sanofi Company,
Published by
Business Wire
10 Oct 12 Sanofi to Launch State-of-the Art, Reusable Insulin Pen AllStar™ in India Sanofi
03 Oct 12 Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement Sanofi
02 Oct 12 The importance of postprandial plasma glucose (PPG) in patients with Type 2 diabetes Sanofi
01 Oct 12 Sanofi appoints Dr. Paul Chew, Chief Medical Officer and Head of Global Medical Affairs Sanofi
26 Jul 12 Sanofi CEO Chris Viehbacher Comments on Results for Q2 2012 Sanofi,
Published by
Business Wire
18 Jul 12 SANOFI ANNOUNCES 2012 PATIENT GROUP BURSARY WINNERS Sanofi UK,
Published by
Just:: Health PR
12 Jul 12 Sanofi Biosurgery Product MACI® Demonstrates Statistically Significant Clinical Outcomes Compared to Microfracture SANOFI,
Published by
PR Newswire
22 Jun 12 Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes Sanofi
18 Jun 12 Sanofi Sponsors 2012 BIO International Convention, Jun 18 - 21, 2012, in Boston MA, US Sanofi,
Published by
Business Wire
15 Jun 12 Sanofi Announces Results of ORIGIN, the World’s Longest and Largest Randomised Clinical Trial in Insulin in Pre- and Early Diabetes Sanofi,
Published by
Business Wire
11 Jun 12 Sanofi Submits Application for Regulatory Approval for Lyxumia® (lixisenatide) for the Treatment of Type 2 Diabetes in Japan Sanofi
11 Jun 12 Lyxumia® (lixisenatide) in combination with insulin demonstrates significant reductions in HbA1C and improvements in post-prandial glucose in patients with Type 2 diabetes Sanofi,
Published by
Red Health
27 Apr 12 Sanofi CFO JĂ©rĂ´me Contamine Comments on Q1 2012 Results Sanofi,
Published by
Business Wire
19 Apr 12 Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson’s Disease Sanofi and Michael J. Fox Foundation
28 Feb 12 Sanofi and the Institut Pasteur create four prestigious awards Sanofi
23 Feb 12 Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis Genzyme a Sanofi Company,
Published by
Business Wire
1 2 3 4 next page
subscribe in a reader
Advertising
Share | | |

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.